Rallis buys majority stake in biotech firm Metahelix

10 Dec 2010 Evaluate

With a view to stepping up its revenues in the seeds space, Rallis India, a subsidiary of Tata Chemicals Ltd, has acquired a majority stake in Metahelix Life Sciences Ltd. With this acquisition the company expects additional cumulative revenue of Rs 1,000 crore by 2015.

The company has picked up a stake of 53.5 per cent in Metahelix for Rs 99.5 crore and will continue to invest in the company and subscribe to an additional equity of Rs 25 crore to increase its stake in Metahelix to 59.02 per cent soon. The company plans further investments with focus on R&D and if required on the processing facilities also.

The Indian seeds market is currently the sixth largest in the world at Rs 6,500 crore and is growing at 12-13 per cent per annum. Metahelix has a product portfolio in rice, maize, millets and vegetable seeds along with good germplasm with many exciting products in the pipeline. It has nationwide sales presence through Dhaanya Seeds, sold through around 1,000 distributors. Metahelix is the first Indian company to have a proprietary Bt trait, cry1C approved in cotton.crackcrack

Rallis India Share Price

291.95 -3.60 (-1.22%)
23-Dec-2024 15:01 View Price Chart
Peers
Company Name CMP
UPL 509.10
BASF India 5635.10
PI Industries 3797.55
Bayer CropScience 5790.00
Sumitomo Chemical India 512.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.